Bioactive Compound Bisacurone in the Turmeric Extract (Turcuron) Prevents Non-alcoholic Fatty Liver Disease by Reduction of Lipogenesis

ABSTRACT

Objectives: The current study was carried out to demonstrate potential role of Turcuron, a standardized turmeric extract containing 8% Bisacurone to protect against non-alcoholic fatty liver disease (NAFLD). Methods: HepG2 cell lines exposed to oleic acid (OA) and high-fat diet-induced hepatic steatosis in mice were used as experimental models to explore the hepatoprotective effects of Turcuron. The cytotoxicity was quantitatively assessed by MTT assay. Lipid accumulation and intracellular triglyceride level were evaluated by oil red O staining. Expressions of SREBP-1c and PPAR- γ proteins in the HepG2 cells and in HFD fed mice liver were examined by western blot. Results: Turcuron suppressed fatty acid synthesis and subsided the oleic acid-induced lipid accumulation in HepG2 cells. Moreover, Turcuron also decreased lipid accumulation in the liver of HFDfed mice compared with the control group. The expression of lipogenic genes involved in hepatic lipid metabolism SREBP-1cand PPAR-γ were decreased both in the HepG2 cells and in the liver of Turcuron supplemented mice. These results suggest that Turcuron may actively ameliorate non-alcoholic fatty liver disease. Conclusion: The findings of the present study provide corroborative scientific evidence that Turcuron may actively ameliorate non-alcoholic fatty liver disease.

KEYWORDS

• NAFLD
• Bisacurone
• SREBP-1
• Oil- O red
• HFD

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.55.1s.36Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 55, ISSUE 1SSolubility Enhancement of Oxcarbazepine by Melt Sonocrystallization Technique to Increase the BioavailabilityVinayak Shivamurthy Mastiholimath, Gauri Pradeep Mashelkar, Vinodkumar Shirshalappa Mannur, Panchaxari Mallappa Dandagi, Pukar Khanal · pp. S56–S65Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1STransdermal Delivery of Fluconazole ß-cyclodextrin Complex Incorporated in Aloe vera Gel for Fungal Therapy: Development, Characterization and in vitro EvaluationDeepak Aswal, Tanuja Bisht · pp. S66–S74Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1SPreparation, Characterization and Optimization of Repurposed Valproic Acid Loaded Carboxymethyl Chitosan Nanoparticles by Box–Behnken Design for Alzheimer ManagementAyush Jaiswal, Senthil Venkatachalam, Anindita De, Bhavesh Namdev, Ravikumar Ramaswamy, Jawahar Natarajan · pp. S75–S86Original ArticleSame type: Article
• Article · VOLUME 55, ISSUE 1SStudies on Formulation and Evaluation of Eudragit RS PO Based Nanoparticulate System of Aceclofenac for Ocular DeliverySfurti Sakhare, Sachin Dnyandeo Shinde, Adhikrao Venkatrao Yadav, Amol Somnath Shete · pp. S87–S99Original ArticleSame type: Article